Share Tweet Share Email

Trustee Murer honored with new appointments to two posts that will advance health research

February 26, 2014
Cherilyn G. Murer

Cherilyn G. Murer

Cherilyn G. Murer, founder, president and CEO of Joliet-based Murer Consultants, Inc., is the recipient of two prestigious appointments among innovators striving to meet the health care needs of the future.

The Clinical and Rehabilitative Medicine Research Program and the U.S. Army have named Murer as a business and technology transfer reviewer on a panel that evaluates applications for the Hypothesis Development Awards and Translational Research Awards of the Vision Research Program (VRP).

She also has accepted a two-year term on the board of directors of Solving Organ Shortage (SOS), an international effort to end the organ shortage through science, partnership and policy.

“I am honored by these invitations to share my expertise in health care matters that require outside-the-box thinking in solving problems,” Murer said.

“My firm is devoted to finding reasonable and achievable solutions for the health care industry that integrate finance, medicine, law and technology, and these two appointments share that strategic approach,” she added. “I look forward to the opportunities and challenges ahead as my new collaborators and I work to improve the quality of life for patients today and tomorrow.”

As a member of the VRP panel, Murer will assess the scientific merit of proposed research projects that could ultimately lead to critical discoveries or major advancements that will drive the field of vision research forward.

Part of the Defense Medical Research and Development Program, the VRP was established in Fiscal Year 2009 to fund innovative research with the potential to significantly improve the health and well-being of active military, veterans and other individuals living with visual dysfunction.

Solving Organ Shortage logoThe mission of SOS is to support development a so-called “just-in-time” organ from a potential recipient’s stem cells; organize as a scientific collaboration; seek formal recognition as an NIH consortium; raise money to purchase stem cells and to support research; and encourage strategic industry partnerships to yield the “just-in-time”organ.

As part of its consortium building program, SOS will sponsor small, invitation-only, organ-specific scientific meetings. The first – the Whole Liver Replacement State-of-the-Science Summit – is scheduled Wednesday, April 30, in Chicago.

Murer has long been an active voice in the advancement of quality, cost-effective health care, combining her law degree from Northern Illinois University with her previous operational experience as the director of Rehabilitation Medicine at Northwestern Memorial Hospital in Chicago.

She is also a current member and former chair of the NIU Board of Trustees. She currently serves as chair of the board’s Ad Hoc Committee on Sponsored Research Activity and Technology Transfer and as chair of the board’s Legislation & External Affairs Committee.